CLDX vs NTLA
Celldex Therapeutics, Inc. - Common Stock · Intellia Therapeutics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CLDX | NTLA |
|---|---|---|
| Price | $32.41 | $12.06 |
| Market Cap | $2.55B | $1.69B |
| P/E | — | — |
| P/B | 3.56 | 2.32 |
| P/S | 1647.34 | 24.97 |
| ROE | -36.2% | -56.7% |
| Net Margin | -16748.0% | -609.9% |
| Gross Margin | — | — |
| Revenue Growth | -78.0% | 16.9% |
| Dividend Yield | — | — |
| EPS | -$3.30 | -$2.95 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.